Michael Engsig – BioLeader Interview

Chief Executive Officer, Nykode Therapeutics (May 2023) Michael Engsig joined Nykode Therapeutics in 2017. He is a broadly anchored pharmaceutical professional with extensive experience, from early-stage drug discovery to late-stage development and product launches in biotech and pharma and across all major geographical areas. His career history includes specialist and managerial roles at Takeda and Nycomed. Michael holds a civil engineering (MSc) degree in chemistry specializing in biotechnology from the Technical University of Denmark, and a Graduate Diploma in Business Administration (HD) in organization and leadership from the Copenhagen Business School (CBS). Key milestones in your career journey to [...]

By |24 May 2023|Categories: BioLeaders|0 Comments

Damian Marron – BioLeader Interview

Board Director Cantargia AB, Targovax ASA, CytoSeek, Imophoron, Resolys Bio (May 2023) Damian Marron is an experienced Board Chair and Non-Executive Director, corporate advisor and former serial Biotech CEO with a successful track record of value creation through public and venture capital financing, portfolio planning, M&A, licensing agreements and R&D collaborations, both as an executive and in advisory roles. He has notably specialized in immuno-oncology, cell therapy and orphan diseases. Damian is currently Non-Executive Chair of the Board at Targovax ASA, Imophoron Ltd and CytoSeek Ltd and Non-Executive Director at Cantargia AB and Resolys Bio Inc. He is also [...]

By |10 May 2023|Categories: BioLeaders|0 Comments

Özgür Tuncer – BioLeader Interview

Chief Executive Officer, Stablepharma, Board Director and Investor (April 2023) Özgür Tuncer has over two decades of experience in the biopharmaceutical industry with deep expertise in executive leadership, strategy, M&A and investments. Most recently, he was Global Vice President in IQVIA, leading company’s Financial Investors practice. In that role, Özgür was involved in more than 300 industry-shaping transactions with valuations of $100m-10bn+, working with world’s leading Private Equity & Venture Capital investors. In addition to being the CEO & Executive Director of Stablepharma, Özgür is an investment partner with Ascension Ventures and co-founder of the Ascension Life Fund. In [...]

By |19 April 2023|Categories: BioLeaders|0 Comments

Camilla Easter – BioLeader Interview

Chief Executive Officer, Oxford Medical Products (April 2023) Oxford Medical Products (OMP) is a clinical staged, VC backed, company providing a non-surgical weight loss product that will redefine the obesity treatment market. Excessive weight affects almost 2 billion people WW, costing the US health system $148bn annually. Our proprietary hydrogel pill is taken orally at home and works like a gastric balloon, without the expense or need for hospital visits. The pills fill 50% of the stomach volume, and stay in the stomach for several weeks, reducing hunger, leading to weight loss. The hydrogel is passed naturally with redosing [...]

By |05 April 2023|Categories: BioLeaders|0 Comments

Nicki Thompson – BioLeader Interview

Chief Executive Officer, Amphista Therapeutics (March 2023) Nicki has over 25 years’ experience in pharmaceutical and biotechnology R&D in a variety of senior scientific and leadership roles. She was previously VP and Global Head of External Drug Discovery at F. Hoffmann-La Roche Ltd and prior to that, Senior Director, Business Development for GSK’s Centre of Excellence for External Drug Discovery (CEEDD). Nicki’s Biotech experience includes her role as Chair of the Board for Nanna Therapeutics Ltd, founding CEO of VirionHealth and Head of Drug Discovery at Syntaxin Ltd. She holds a PhD in Cell Biology from University College London. [...]

By |15 March 2023|Categories: BioLeaders|0 Comments

David Reynolds – BioLeader Interview

David Reynolds BioLeader Interview - David Reynolds, Chief Executive Officer, LoQus23 Therapeutics, Non-Executive Director, AstronauTx (March 2023) David is a highly experienced pharmaceutical research and development leader having worked for nearly 20 years at Merck Sharp & Dohme, Lundbeck and latterly Pfizer, where he was the Cambridge Neuroscience & Pain Research Site Head. He has held a variety of R&D leadership roles with responsibilities ranging from exploratory biology, through drug discovery, early clinical development and in-licensing in multiple disease areas, with a focus on neuroscience and pain. Before joining the Dementia Discovery Fund he spent three years as the [...]

By |01 March 2023|Categories: BioLeaders|0 Comments

Matt Regan – BioLeader Interview

Matt Regan BioLeader Interview - Matt Regan, Chief Executive Officer, Micreos Pharmaceuticals (February 2023) Senior, international, Healthcare leader with 30-years of research-based Biopharmaceutical & Medical device experience with Global leaders such as Abbott, AbbVie and Novo Nordisk. Currently CEO with the Clinical stage Biotech Company Micreos Pharma. Broad, diverse experience having held leadership roles in Manufacturing, Engineering, Supply Chain management, HR management, Research & Development as well as very significant commercial leadership roles at the Country and Regional level. Authentic, values-driven leader with the ability to inspire large organizations to transform, to build new capabilities, and to raise the [...]

By |08 February 2023|Categories: BioLeaders|0 Comments

David Van Sickle – BioLeader Interview

David Van Sickle BioLeader Interview - David Van Sickle, Healthtech Entrepreneur, Executive and Board Director (December 2022) I have more than 15 years experience developing and commercializing digital health technologies. From 2010, I was the co-founder and CEO of Propeller Health, a digital health + therapeutics company dedicated to improving the management of asthma and COPD. At Propeller, we pioneered the application of digital technology to chronic disease management and pharmaceutical therapy. During the company's history, we partnered with health plans, provider systems, PBMs, retail pharmacies, and pharmaceutical manufacturers to bring clinically-proven digital solutions to clinicians and people with [...]

By |07 December 2022|Categories: BioLeaders|0 Comments

Hakim Yadi – BioLeader Interview

Hakim Yadi BioLeader Interview - Hakim Yadi, Chief Executive Officer & Co-Founder, Closed Loop Medicine (September 2022) Hakim is a Co-Founder and Chief Executive Officer of Closed Loop Medicine (CLM). CLM is a healthcare technology company developing drug + digital combination products, transforming drug effectiveness through optimisation by providing every drug its real time digital companion. Hakim joined Closed Loop Medicine from the Northern Health Science Alliance Ltd, the pan-Northern health partnership which brought together for the first time 20 research-based NHS hospitals, the North’s Academic Health Science Networks and Universities to collaborate on improving health outcomes across the [...]

By |28 September 2022|Categories: BioLeaders|0 Comments

Jorge Quiroz – BioLeader Interview

Jorge Quiroz BioLeader Interview - Jorge Quiroz, Executive Vice President, Chief Medical Officer, NMD Pharma, Boston USA (September 2022) Dr. Quiroz brings twenty years of drug development experience in academic, pharmaceutical and biotechnology industries. He has been responsible for the scientific, clinical, and regulatory strategies across all phases of drug development, globally, including IND filings for rare disorders, and proof of concept and registrational studies for NDA and sNDA. He currently serves as a member of the Board of Directors of Perception Neurosciences and prior to NMD Pharma, Dr. Quiroz served as Chief Medical Officer of venture backed and [...]

By |07 September 2022|Categories: BioLeaders|0 Comments
Go to Top